Search This Blog

Wednesday, August 7, 2019

Rocket Pharmaceuticals EPS beats by $0.23

Rocket Pharmaceuticals (NASDAQ:RCKT): Q2 GAAP EPS of -$0.38 beats by $0.23.
Cash, equivalents and investments of $257.78M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)